Compounds > fluoxetine

fluoxetine and vofopitant

fluoxetine has been researched along with vofopitant in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carlson, EC; de Felipe, C; Harrison, T; Hunt, S; Oates, B; Owen, S; Rupniak, NM; Seward, E; Wheeldon, A1
Arban, R; Bettelini, L; Corsi, M; Gerrard, PA; Griffante, C; Marchi, M; Varnier, G; Zanetti, L; Zocchi, A1
Carboni, L; Castelletti, L; Domenici, E; Milli, A; Piubelli, C; Vighini, M1
Bouchez, G; Brocco, M; Dekeyne, A; Di Cara, B; Gannon, RL; Gobert, A; Lejeune, F; Millan, MJ1

Other Studies

4 other study(ies) available for fluoxetine and vofopitant

ArticleYear
Pharmacological blockade or genetic deletion of substance P (NK(1)) receptors attenuates neonatal vocalisation in guinea-pigs and mice.
    Neuropharmacology, 2000, Jun-08, Volume: 39, Issue:8

    Topics: Animals; Animals, Newborn; Anti-Anxiety Agents; Antidepressive Agents; Behavior, Animal; Buspirone; Diazepam; Dose-Response Relationship, Drug; Female; Fluoxetine; Gene Deletion; Guinea Pigs; Imipramine; Injections, Intraventricular; Male; Mice; Mice, Inbred Strains; Motor Activity; Neurokinin-1 Receptor Antagonists; Peptide Fragments; Piperidines; Receptors, Neurokinin-1; Social Isolation; Stress, Psychological; Substance P; Tetrazoles; Vocalization, Animal

2000
Effects of antidepressant drugs and GR 205171, an neurokinin-1 (NK1) receptor antagonist, on the response in the forced swim test and on monoamine extracellular levels in the frontal cortex of the mouse.
    Neuroscience letters, 2003, Jul-17, Volume: 345, Issue:2

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Biogenic Monoamines; Bupropion; Extracellular Space; Fluoxetine; Immobilization; Mice; Mice, Inbred Strains; Neurokinin-1 Receptor Antagonists; Piperidines; Prefrontal Cortex; Swimming; Tetrazoles; Time Factors

2003
Proteomic analysis of rat hippocampus and frontal cortex after chronic treatment with fluoxetine or putative novel antidepressants: CRF1 and NK1 receptor antagonists.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2006, Volume: 16, Issue:7

    Topics: Animals; Antidepressive Agents; Blotting, Western; Electrophoresis, Gel, Two-Dimensional; Fluoxetine; Frontal Lobe; Hippocampus; Male; Neurokinin-1 Receptor Antagonists; Peptide Mapping; Piperidines; Proteomics; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Spectrum Analysis; Tetrazoles; Triazines

2006
Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and behavioral characterization.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:4

    Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Behavior, Animal; Brain; Citalopram; Cricetinae; Dopamine; Drug Synergism; Fluoxetine; Gerbillinae; Isoindoles; Male; Mesocricetus; Mice; Neurokinin-1 Receptor Antagonists; Neurons; Norepinephrine; Piperidines; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Tetrazoles

2009